RANKINGS

Key list: emerging companies in Europe by revenue

Powered by 

This month our pharma industry key list brings you the 15 leading emerging companies in Europe by revenue, as ranked by GlobalData's Pharma Intelligence Centre. All numbers up to date as of July 2021.

Company name

Headquarters location  

No. of employeesRevenue ($m)

Ipsen SA

France

5,7033,015

Endo International Plc    

Ireland3,3972,914

H. Lundbeck AS

Denmark5,6282,555

Jazz Pharmaceuticals Plc

Ireland1,9402,162

Vifor Pharma Ltd

Switzerland2,6001,919

Richter Gedeon Nyrt

Hungary12,7701,749

Swedish Orphan Biovitrum AB

Sweden1,5081,508

Orion Corp

Finland3,3441,177

Alkermes Plc

Ireland2,2451,171

Almirall SA

Spain1,786958

Laboratorios Farmaceuticos Rovi SA

Spain1,419427

CRISPR Therapeutics AG

Switzerland410290

Pharming Group NV

Netherlands262189

Valneva SE

France532141

Bavarian Nordic A/S

Denmark71199
Go to article: Home | Waive goodbye to vaccine patentsGo to article: In this issueGo to article: ContentsGo to article: Mimotopes Company Insight Go to article: MimotopesGo to article: DatwylerGo to article: Datwyler Company InsightGo to article: LabcorpGo to article: Biesterfeld Go to article: BriefingGo to article: Industry newsGo to article: The pharma industry briefingGo to article: Covid-19 executive briefing by GlobalDataGo to article: Dr. Paul LohmannGo to article: ButterworthGo to article: SkyepharmaGo to article: BaxterGo to article: CommentGo to article: Speeding up patient access to innovative drugsGo to article: The competitive landscape of neoantigen-targeting therapeutics in oncologyGo to article: Bacterial “cell factories”: an eco-friendly approach to chemical productionGo to article: MDR set to transform how MedTech firms approach content managementGo to article: PerkinElmerGo to article: NiproGo to article: NiproGo to article: In DepthGo to article: Should UK children be vaccinated against chickenpox?Go to article: Fighting India’s ‘black fungus’ epidemicGo to article: What could a vaccine patent waiver mean for pharma manufacturing? Go to article: Algae proteins: a vision of the futureGo to article: A brief history of ALS awareness and its sparse treatments Go to article: Ferring draws closer to a microbiome breakthroughGo to article: The Solubility companyGo to article: Myonex Go to article: Owen MumfordGo to article: In DataGo to article: Data: pharma subsidiaries Go to article: Deals analysisGo to article: The pharma industry key listGo to article: Global markets and indicesGo to article:  Macro-economic indicatorsGo to article: Macro-economic indicators (page 2)Go to article: EventsGo to article: Next issue